Double-blind drug clinical test method and system

A technology of clinical trials and drugs, applied in the direction of drugs or prescriptions, can solve problems such as drug waste, achieve the effects of saving drugs, solving drug waste, and optimizing the distribution process

Pending Publication Date: 2020-11-10
西安康博瑞生命科学技术有限公司
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Embodiments of the present invention provide a double-blind drug clinical trial method and system to at least solve the technical problem of drug waste in existing blind clinical trials

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-blind drug clinical test method and system
  • Double-blind drug clinical test method and system
  • Double-blind drug clinical test method and system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] According to an embodiment of the present invention, a method embodiment of a double-blind drug clinical trial method is provided. It should be noted that the steps shown in the flow chart of the accompanying drawings can be executed in a computer system such as a set of computer-executable instructions , and, although a logical order is shown in the flowcharts, in some cases the steps shown or described may be performed in an order different from that shown or described herein.

[0027] figure 1 It is the double-blind drug clinical trial method according to the embodiment of the present invention, such as figure 1 As shown, the method includes the following steps:

[0028] Step S101, generating a random allocation table, a drug number table, and a secondary blind comparison table.

[0029] In the above step S101 of the present application, at the beginning of the test, firstly, two random control tables (ie, random allocation table and drug number table) and one seco...

Embodiment 2

[0049] According to an embodiment of the present invention, a double-blind drug clinical trial system is also provided, such as figure 2 As shown, the double-blind drug clinical trial system includes: an input unit 201, which is used to receive the basic information of the target object; a screening unit 202, which is used to screen the target object based on the basic information and preset inclusion and exclusion criteria; a processing unit 203, for extracting the first random number from the pre-generated random allocation table and assigning it to the target object; obtaining the group corresponding to the first random number from the pre-generated secondary blind comparison table; In the table, according to the order of drug numbers from small to large, the drugs corresponding to the groups are assigned to the target objects.

[0050] Optionally, the random allocation table includes random numbers, group numbers, blocks and random numbers.

[0051]Optionally, the drug n...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a double-blind drug clinical test method and a double-blind drug clinical test system. The method comprises the following steps: generating a random allocation table, a drug number table and a secondary blind base comparison table; extracting a first random number from the random allocation table and allocating the first random number to a target object; obtaining a group corresponding to the first random number from the secondary blind base comparison table; and distributing the medicines corresponding to the groups to the target object from the medicine distribution table according to the sequence of the medicine numbers from small to large. The technical problem of medicine waste in an existing blind clinical test is solved.

Description

technical field [0001] The invention relates to the field of drug clinical trials, in particular to a double-blind drug clinical trial method and system. Background technique [0002] A new drug clinical trial refers to any systematic study of a drug in humans (patients or healthy volunteers) to confirm or discover the clinical, pharmacological and / or other pharmacodynamic effects, adverse reactions and / or absorption of the experimental drug , distribution, metabolism and excretion, the purpose is to determine the safety and effectiveness of the experimental drug, and provide a basis for the marketing of innovative drugs (or generic drugs). In order to obtain a more objective effect, a series of measures are taken so that those who affect the results of clinical trials do not know "which patient received which treatment" when the patient is receiving treatment, and even statistical analysis. These measures are usually called "blinding". . A "blinded" trial is called a "bli...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G16H20/13
CPCG16H20/13
Inventor 蔡宏伟夏林莺
Owner 西安康博瑞生命科学技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products